{"title":"Clinical Characteristics of COVID-19 in Active or Previously Treated Tuberculosis Patients in Turkey","authors":"Sumeyra Kayali, Fatma Nur Karaçorlu, Mustafa YILMAZ, Zulal Aşçı Toraman, E. Pirinççi","doi":"10.4274/haseki.galenos.2022.8327","DOIUrl":null,"url":null,"abstract":"Aim: There is limited literature on coronavirus disease-2019 (COVID-19) and tuberculosis (TB) coinfection, although high rates of coinfection between COVID-19 and other respiratory pathogens are expected. To the best of our knowledge, this is the first study to examine COVID-19 infection in patients diagnosed with active or previously treated TB in Turkey. In this study, the aim was to examine the frequency of COVID-19 and the factors affecting the frequency of COVID-19 in patients with active or previously treated TB. Method(s): The population of the retrospective cohort type study consisted of patients with TB enrolled in the Elazig Tuberculosis Dispensary between January 2015 and April 2021. The TB-related data of the patients was obtained from the Public Health Management System Tuberculosis System, and the COVID-19 information was obtained from the COVID-19 Case Tracking System. The status of being alive or dead and the date of death if they were dead were obtained from the Central Population Management System. Result(s): 23.92% (n=105) of 439 patients with TB were COVID-19 cases. Advanced age, having at least one comorbid disease, and the presence of chronic pulmonary disease, diabetes mellitus, and heart disease increased the risk of developing COVID-19 in active or previously treated patients with TB. Conclusion(s): COVID-19 was detected more frequently in active or previously treated TB patients than in the general population. Within the scope of public health services implemented to prevent the spread of COVID-19 infection, priority should be given to the TB patient group and older people, especially those with comorbid chronic pulmonary disease, diabetes mellitus, and heart disease in this group. Copyright © 2022 by The Medical Bulletin of Istanbul Haseki Training and Research Hospital The Medical Bulletin of Haseki published by Galenos Yayinevi.","PeriodicalId":42416,"journal":{"name":"Haseki TIp Bulteni-Medical Bulletin of Haseki","volume":"27 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haseki TIp Bulteni-Medical Bulletin of Haseki","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/haseki.galenos.2022.8327","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
土耳其活动性或既往治疗过的结核病患者中COVID-19的临床特征
目的:关于冠状病毒病-2019 (COVID-19)和结核病(TB)合并感染的文献有限,尽管预计COVID-19与其他呼吸道病原体的合并感染率很高。据我们所知,这是首个在土耳其检查被诊断为活动性结核病或曾接受过治疗的结核病患者中COVID-19感染情况的研究。本研究旨在探讨活动性或既往治疗过的结核病患者中COVID-19的发病频率及其影响因素。方法:回顾性队列型研究的人群包括2015年1月至2021年4月在Elazig结核病药房登记的结核病患者。患者结核病相关数据来自公共卫生管理系统结核病系统,COVID-19信息来自COVID-19病例跟踪系统。他们的生死状况及死亡日期均由中央人口管理系统查询。结果:439例TB患者中有23.92% (n=105)为COVID-19病例。高龄、至少有一种合并症以及存在慢性肺病、糖尿病和心脏病增加了活动性或既往治疗过的结核病患者发生COVID-19的风险。结论:与一般人群相比,在活动性或既往治疗过的结核病患者中检测到COVID-19的频率更高。在为预防COVID-19感染传播而实施的公共卫生服务范围内,应优先考虑结核病患者群体和老年人,特别是这一群体中合并慢性肺病、糖尿病和心脏病的人群。伊斯坦布尔Haseki培训和研究医院医学公报版权所有©2022。Galenos Yayinevi出版的Haseki医学公报。
本文章由计算机程序翻译,如有差异,请以英文原文为准。